Pharmaceutical compositions containing famotidine and aluminum hydroxide or magnesium hydroxide
November 25, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3048526 3922338 Simethicone antacid tablet Guanidinothiazole compounds, process for preparation and gastric inhibiting compositions containing them Taste masking and sustained release coatings for pharmaceuticals Controlled release article with pulsatile release Methods and pharmaceutical compositions for treating episodic heartburn Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets Patent #: 5260072 InventorsAssigneeApplicationNo. 756080 filed on 11/25/1996US Classes:424/470, Where particles are granulated424/455, Containing emulsions, dispersions, or solutions424/464, Tablets, lozenges, or pills424/472, Layered unitary dosage forms424/473, With porous, perforated, apertured, or sieved layer (e.g., dialyzing layer, microporous layer, etc.)424/490, Coated (e.g., microcapsules)424/493, Containing polysaccharides (e.g., sugars)424/494, Cellulose derivatives424/495, Ethyl cellulose424/497, Containing solid synthetic polymers424/498, Containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof424/687, Calcium carbonate424/690, Aluminum hydroxide424/692, Magnesium hydroxide or oxide514/370Nitrogen bonded directly to ring carbon of the thiazole ringExaminersPrimary: Cintins, Marianne M.Assistant: Moezie, M. Attorney, Agent or FirmForeign Patent References
International ClassesA61K 009/26A61K 009/16 A61K 009/50 AbstractA solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of a therapeutically effective amount of guanidinothiazole compound; and a therapeutically effective amount of an antacid wherein the pharmaceutical and an antacid are separated by a barrier which is substantially impermeable to an antacid.Other References
Field of SearchTablets, lozenges, or pillsLayered unitary dosage forms With porous, perforated, apertured, or sieved layer (e.g., dialyzing layer, microporous layer, etc.) Containing emulsions, dispersions, or solutions Calcium carbonate Aluminum hydroxide Magnesium hydroxide or oxide Where particles are granulated Coated (e.g., microcapsules) Containing polysaccharides (e.g., sugars) Cellulose derivatives Ethyl cellulose Containing solid synthetic polymers Containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof Nitrogen bonded directly to ring carbon of the thiazole ring | |
